Back to Treatments

Treatment

Concurrent Chemoradiation (Cisplatin-based)

2
Conditions
71
Trials
130K
Participants
25%
Average Safety

Condition Evidence

Cervical cancer

67 trials · 50K participants

85% effectiveness · 25% safety

Larynx cancer

4 trials · 80K participants

85% effectiveness · 25% safety
Concurrent Chemoradiation (Cisplatin-based) | DFDA